Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)
Sponsor: Zai Lab (Shanghai) Co., Ltd.
Summary
The purpose of this study is to evaluate the efficacy and safety of ZL-1310 compared to Investigator's Choice Therapy in participants with relapsed Small Cell Lung Cancer.
Official title: A Randomized, Open-Label, Phase 3 Study of ZL-1310, a DLL3 Antibody-Drug Conjugate (ADC), Compared to Investigator's Choice Therapy in Participants With Relapsed Small Cell Lung Cancer
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
480
Start Date
2025-11-30
Completion Date
2028-11-30
Last Updated
2026-05-14
Healthy Volunteers
No
Conditions
Interventions
ZL-1310
ZL-1310 as a single-agent
Investigator's Choice of Therapy
Topotecan, Lurbinectedin, or Amrubicin
Locations (56)
Zai Lab Site 02037
Aurora, Colorado, United States
Zai Lab Site 02030
New Haven, Connecticut, United States
Zai Lab Site 02045
Clermont, Florida, United States
Zai Lab Site 02031
Orange City, Florida, United States
Zai Lab Site 02020
Rockledge, Florida, United States
Zai Lab Site 02026
Sarasota, Florida, United States
Zai Lab Site 02052
St. Petersburg, Florida, United States
Zai Lab Site 02051
West Palm Beach, Florida, United States
Zai Lab Site 02021
Peoria, Illinois, United States
Zai Lab Site 02049
Peoria, Illinois, United States
Zai Lab Site 02038
Iowa City, Iowa, United States
Zai Lab Site 02041
Louisville, Kentucky, United States
Zai Lab Site 02003
Bethesda, Maryland, United States
Zai Lab Site 02022
Silver Spring, Maryland, United States
Zai Lab Site 02010
Detroit, Michigan, United States
Zai Lab Site 02023
Columbia, Missouri, United States
Zai Lab Site 02009
St Louis, Missouri, United States
Zai Lab Site 02040
The Bronx, New York, United States
Zai Lab Site 02024
Cleveland, Ohio, United States
Zai Lab Site 02035
Broomall, Pennsylvania, United States
Zai Lab Site 02019
Media, Pennsylvania, United States
Zai Lab Site 02008
Pittsburgh, Pennsylvania, United States
Zai Lab Site 02029
Pittsburgh, Pennsylvania, United States
Zai Lab Site 02036
Nashville, Tennessee, United States
Zai Lab Site 02025
Austin, Texas, United States
Zai Lab Site 02046
Dallas, Texas, United States
Zai Lab Site 02025
Odessa, Texas, United States
Zai Lab Site 02006
Fairfax, Virginia, United States
Zai Lab Site 01002
Hefei, Anhui, China
Zai Lab Site 01014
Xiamen, Fujian, China
Zai Lab Site 01001
Guangzhou, Guangdong, China
Zai Lab Site 01011
Naning, Guangxi, China
Zai Lab Site 01008
Shijiazhuang, Hebei, China
Zai Lab Site 01010
Zhengzhou, Henan, China
Zai Lab Site 01034
Wuhan, Hubei, China
Zai Lab Site 01012
Nanjing, Jiangsu, China
Zai Lab Site 01015
Nanchang, Jiangxi, China
Zai Lab Site 01009
Xi'an, Shaanxi, China
Zai Lab Site 01007
Jinan, Shandong, China
Zai Lab Site 01005
Linyi, Shandong, China
Zai Lab Site 01043
Shanghai, Shanghai Municipality, China
Zai Lab SIte 01026
Chengdu, Sichuan, China
Zai Lab Site 01017
Hangzhou, Zhejiang, China
Zai Lab Site 01016
Taizhou, Zhejiang, China
Zai Lab Site 10019
Kurume, Fukuoka, Japan
Zai Lab Site 10015
Kashihara, Nara, Japan
Zai Lab Site 10014
Izumi, Osaka, Japan
Zai Lab Site 10010
Shizuoka, Sunto-gun, Japan
Zai Lab Site 10003
Shimosuga, Tochigi, Japan
Zai Lab Site 10008
Bunkyō-Ku, Tokyo, Japan
Zai Lab Site 10006
Bunkyō-Ku, Tokyo, Japan
Zai Lab Site 10005
Koto-Ku, Tokyo, Japan
Zai Lab Site 10007
Shinjuku-Ku, Tokyo, Japan
Zai Lab Site 10018
Fukuoka, Japan
Zai Lab Site 10017
Fukuoka, Japan
Zai Lab Site 10013
Osaka, Japan